What are the guidelines on the use of HCQ by pregnant women with rheumatoid arthritis (RA)?

Updated: May 11, 2018
  • Author: Katherine K Temprano, MD; Chief Editor: Christine Isaacs, MD  more...
  • Print
Answer

Answer

BSR-BHPR guidelines find HCQ the antimalarial of choice in women with rheumatic disease who are planning a pregnancy and recommend continuing use during pregnancy. [19]  EULAR guidelines also support use throughout pregnancy, based on current evidence indicating no increased rate of congenital malformations. [18]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!